acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule

RxCUI
1431286
RxNorm name
acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
Display name
Acetaminophen/Butalbital/Caffeine/Codeine (Oral Pill)
Full name
acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
Term type
SCD
Status
Active
Strength
300-50-40-30 mg
Dose form
Cap
Route
Oral Pill
Updated
2026-10-17 23:55:42

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082013
Active start
082013
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
acetaminophen300 MG / 1 EACHacetaminophenacetaminophen
caffeine40 MG / 1 EACHcaffeinecaffeine
butalbital50 MG / 1 EACHbutalbitalbutalbital
codeine phosphate30 MG / 1 EACHcodeinecodeine phosphate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Capsule316965

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
acetaminophen161
caffeine1886
butalbital19860
codeine2670

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0054-0650-250054-0650Butalbital, Acetaminophen, Caffeine and Codeine Phosphate Butalbital, Acetaminophen, Caffeine and Codeine PhosphateHikma Pharmaceuticals USA Inc.ANDA215138
0591-2641-010591-2641Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateActavis Pharma, Inc.ANDA076560

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA2151380054-0650Butalbital, Acetaminophen, Caffeine and Codeine Phosphate Butalbital, Acetaminophen, Caffeine and Codeine PhosphateANDAHikma Pharmaceuticals USA Inc.
ANDA0765600591-2641Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateANDAActavis Pharma, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 6 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00054065025rxnav_ndcsyes
00591264101rxnav_ndcsyes
00722702801rxnav_historical
00722702805rxnav_historical
79739702801rxnav_historical
79739702805rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Butalbital, Acetaminophen, Caffeine and Codeine PhosphateBUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATEHikma Pharmaceuticals USA Inc.6e0e8abc-512b-42f7-8323-434c589edecf2026-01-02Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0054-0650-25
ndc (product): 0054-0650
ndc11 (package): 00054065025
rxcui: 1431286
Butalbital, Acetaminophen, Caffeine, and Codeine PhosphateBUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATEActavis Pharma, Inc.52321fe5-c001-4e2d-8149-3197ddc137642025-12-10Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 0591-2641-01
ndc (product): 0591-2641
ndc11 (package): 00591264101
rxcui: 1431286

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
df9801fc-03fe-41da-a6b3-0f76788217c9butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY]311These highlights do not include all the information needed to use FIORICET with CODEINE safely and effectively. See full prescribing information for FIORICET with CODEINE. FIORICET ® with CODEINE (butalbital, acetaminophen, caffeine, and codeine phosphate) Capsules, for oral use, CIII Initial U.S. Approval: 199220210301
8f8c5c01-5859-4843-adf4-8116ddaedc90butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY]311These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 199220200221
52321fe5-c001-4e2d-8149-3197ddc13764butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY]310These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII Initial U.S. Approval: 199220251210
6e0e8abc-512b-42f7-8323-434c589edecfbutalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY]36These highlights do not include all the information needed to use BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES safely and effectively. See full prescribing information for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES. BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE capsules, for oral use, CIII Initial U.S. Approval: 199220260102
b96c0356-39e3-496a-a622-603f8a91f49ebutalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY]32These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 199220210614

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
6e0e8abc-512b-42f7-8323-434c589edecfThese highlights do not include all the information needed to use BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES safely and effectively. See full prescribing information for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES. BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE capsules, for oral use, CIII Initial U.S. Approval: 1992Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc.20260102
52321fe5-c001-4e2d-8149-3197ddc13764These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII Initial U.S. Approval: 1992Actavis Pharma, Inc.20251210
b96c0356-39e3-496a-a622-603f8a91f49eThese highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 1992LGM Pharma Solutions, LLC20210614
8f8c5c01-5859-4843-adf4-8116ddaedc90These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 1992Nexgen Pharma, Inc.20200221

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCR05DAOpium alkaloids and derivativesATC1-4codeine
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD001463BarbituratesCHEMhas_chemical_structurebutalbital
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175693BarbiturateEPChas_epcbutalbital
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001463BarbituratesCHEMhas_ingredientbutalbital
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD003061CodeineCHEMhas_ingredientcodeine phosphate
MEDRTD003061CodeineCHEMhas_ingredientcodeine
MEDRTD009020MorphineCHEMhas_active_metabolitescodeine phosphate
MEDRTD009020MorphineCHEMhas_active_metabolitescodeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001249AsthmaDISEASEci_withcodeine
MEDRTD001249AsthmaDISEASEci_withcodeine phosphate
MEDRTD003371CoughDISEASEmay_treatcodeine
MEDRTD003371CoughDISEASEmay_treatcodeine phosphate
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withbutalbital
MEDRTD004342Drug HypersensitivityDISEASEci_withcodeine
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD004342Drug HypersensitivityDISEASEci_withcodeine phosphate
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006261HeadacheDISEASEmay_treatbutalbital
MEDRTD007415Intestinal ObstructionDISEASEci_withcodeine phosphate
MEDRTD007415Intestinal ObstructionDISEASEci_withcodeine
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD010146PainDISEASEmay_treatcodeine phosphate
MEDRTD010146PainDISEASEmay_treatcodeine
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD011164PorphyriasDISEASEci_withbutalbital
MEDRTD011247PregnancyDISEASEci_withcodeine
MEDRTD011247PregnancyDISEASEci_withbutalbital
MEDRTD011247PregnancyDISEASEci_withcodeine phosphate
MEDRTD012131Respiratory InsufficiencyDISEASEci_withcodeine
MEDRTD012131Respiratory InsufficiencyDISEASEci_withcodeine phosphate
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000175684Full Opioid AgonistsMOAhas_moacodeine
MEDRTN0000175684Full Opioid AgonistsMOAhas_moacodeine phosphate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacodeine phosphate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacodeine
MEDRTN0000000105Neurotransmitter Transporter InteractionsMOAhas_moabutalbital
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000175439AnalgesiaPEhas_pecodeine phosphate
MEDRTN0000175439AnalgesiaPEhas_pecodeine
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pecodeine
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pecodeine phosphate
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pecodeine
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pecodeine phosphate
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pebutalbital
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismcodeine phosphate
MEDRTN0000000026Hepatic MetabolismPKhas_pkcodeine phosphate
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismcodeine
MEDRTN0000000026Hepatic MetabolismPKhas_pkcodeine
MEDRTN0000000042Renal ExcretionPKhas_pkcodeine phosphate
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkcodeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH300 MG / 50 MG / 40 MG / 30 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE3
CODESANDAANDA076560
CODESANDAANDA215138
CODESVUID4032595
NAMESPrescribable Synonymbutalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File